A Double Blind, Randomized Controlled Trial Examining the Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-abdominal Collections in Children - a Prospective Study

Trial Profile

A Double Blind, Randomized Controlled Trial Examining the Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-abdominal Collections in Children - a Prospective Study

Suspended
Phase of Trial: Phase III

Latest Information Update: 08 May 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Abscess
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 02 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 02 May 2017 Status changed from recruiting to suspended due to slow accrual. interim analysis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top